Mesoblast (MESO) FCF Margin (2014 - 2023)
Mesoblast (MESO) reported FCF Margin of -35.76% for the year ended Jun 30, 2026, up 250.75 percentage points from -286.51% a year earlier.
Analysis
Mesoblast (MESO) FCF Margin (2014 - 2023) Analysis & Trends
Dating back to the year ended Jun 30, 2015, Mesoblast's FCF Margin record includes 12 years.
- FCF Margin has increased for three consecutive years, with a five-year change of +1319.49 percentage points (years ended Jun 2021 to Jun 2026).
- The figure for the year ended Jun 30, 2026 ranks as the highest annual FCF Margin in data going back to the year ended Jun 30, 2015.
- According to Business Quant data, FCF Margin came in at -286.51% in the year ended Jun 30, 2025 (+529.94 pp), -816.45% in the year ended Jun 30, 2024 (+23.50 pp), -839.95% in the year ended Jun 30, 2023 (-195.73 pp) and -644.23% in the year ended Jun 30, 2022 (+711.02 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 33.69% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 25.03% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 41.97% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 30.51% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 38.60% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 35.25% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 57.81% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 28.96% |
| 10 | Mesoblast | 1.84 Bn | 1.40 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -760.40% |
| Mar 31, 2023 | -840.12% |
| Dec 31, 2022 | -774.98% |
| Sep 30, 2022 | -960.75% |
| Jun 30, 2022 | -623.47% |
| Mar 31, 2022 | -772.05% |
| Dec 31, 2021 | -764.37% |
| Sep 30, 2021 | -509.13% |
| Jun 30, 2021 | -970.25% |
| Mar 31, 2021 | -1,297.60% |
| Dec 31, 2020 | -1,346.41% |
| Sep 30, 2020 | -2,164.60% |
| Jun 30, 2020 | -2,057.92% |
| Mar 31, 2020 | -168.74% |
| Dec 31, 2019 | -81.10% |
| Sep 30, 2019 | -92.16% |
| Jun 30, 2019 | -974.22% |
| Mar 31, 2019 | -1,703.68% |
| Dec 31, 2018 | 104.60% |
| Sep 30, 2018 | -168.28% |
API Access
Mesoblast FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=MESO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "MESO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=MESO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();